Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 19/20 | 0.50 |
| ▸ | MAOA | P21397 | 19/20 | 0.50 |
| ▸ | MAOB | P27338 | 19/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9666944 | 0.76 | KDM1A (0.48) | KDM1AMAOAMAOB | |
| SCHEMBL12946117 | 0.71 | KDM1A (0.67) | KDM1AMAOAMAOB | |
| SCHEMBL6937547 | 0.69 | TRPA1 (0.41) | KDM1AMAOAMAOB | |
| SCHEMBL12054818 | 0.68 | KDM1A (0.47) | KDM1AMAOAMAOB | |
| SCHEMBL4993041 | 0.68 | SLC18A3 (0.40) | KDM1AMAOAMAOB | |
| SCHEMBL23465403 | 0.67 | KDM1A (1.00) | KDM1AMAOAMAOB | |
| SCHEMBL15767313 | 0.67 | KDM1A (1.00) | KDM1AMAOAMAOB | |
| SCHEMBL4129786 | 0.67 | KDM1A (1.00) | KDM1AMAOAMAOB | |
| SCHEMBL15541008 | 0.67 | KDM1A (1.00) | KDM1AMAOAMAOB | |
| SCHEMBL15541945 | 0.67 | KDM1A (1.00) | KDM1AMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113372235-B | Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acids | 佛山奕安赛医药科技有限公司 | 2022-08-19 | — | — | CN | claimed |
| CN-113372235-A | Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acid | 佛山奕安赛医药科技有限公司 | 2021-09-10 | — | — | CN | claimed |
| CN-113372235-B | Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acids | 佛山奕安赛医药科技有限公司 | 2022-08-19 | — | — | CN | disclosed |
| CN-113372235-B | Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acids | 佛山奕安赛医药科技有限公司 | 2022-08-19 | — | — | CN | disclosed |
| CN-113372235-A | Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acid | 佛山奕安赛医药科技有限公司 | 2021-09-10 | — | — | CN | disclosed |
| CN-113372235-A | Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acid | 佛山奕安赛医药科技有限公司 | 2021-09-10 | — | — | CN | disclosed |
| US-7589066-B2 | Such as N-carbobenzyloxy-phenylalanyl-phenylalanylal; for treating cancer, inflammation, and/or autoimmune diseases; suppresses endogenous antigenic peptide generation | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2009-09-15 | — | — | US | disclosed |
| EP-1863513-A2 | POTENT AND SPECIFIC IMMUNOPROTEASOME INHIBITORS | The University of North Carolina at Chapel Hill (US) | 2007-12-12 | — | — | EP | disclosed |
| US-20060241056-A1 | Potent and specific immunoproteasome inhibitors | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2006-10-26 | — | — | US | disclosed |
| WO-2006099261-A2 | POTENT AND SPECIFIC IMMUNOPROTEASOME INHIBITORS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2006-09-21 | — | — | WO | disclosed |
| US-4954158-A | INHIBIT ETHYLENE PRODUCTION IN PLANTS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1990-09-04 | — | — | US | disclosed |
| WO-1990007260-A2 | 2,3-METHANOPROLINE | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1990-07-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241056-A1 | Potent and specific immunoproteasome inhibitors | SERPINB1, DNPEP, PSMB2 | KDM1A 1761/4885MAOA 3795/4885MAOB 3731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.